Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RIOK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SMIM14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EHBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCMTD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YES1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LNPK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF706 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDZD8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPY30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ACER3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FREM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP11A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP2C1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLGN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKDC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCYOX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC91 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on